Hany A Abdel-Hafiz

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Top Venues

Science advances

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Hany A Abdel-Hafiz, Johanna M Schafer, Xingyu Chen, Tong Xiao, Timothy D Gauntner, Zihai Li, Dan Theodorescu
Author Correction: Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature (2024)
Hany A Abdel-Hafiz, Johanna M Schafer, Xingyu Chen, Tong Xiao, Timothy D Gauntner, Zihai Li, Dan Theodorescu
Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature (2023)
Megan M Tu, Hany A Abdel-Hafiz, Robert T Jones, Annie Jean, Katelyn J Hoff, Jason E Duex, Ana Chauca-Diaz, James C Costello, Garrett M Dancik, Beth Ann Jiron Tamburini, Bogdan Czerniak, Jonathan Kaye, Dan Theodorescu
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Communications biology 3 (1) (2020)
Megan M Tu, Francis Y F Lee, Robert T Jones, Abigail K Kimball, Elizabeth Saravia, Robert F Graziano, Brianne Coleman, Krista Menard, Jun Yan, Erin Michaud, Han Chang, Hany A Abdel-Hafiz, Andrii I Rozhok, Jason E Duex, Neeraj Agarwal, Ana Chauca-Diaz, Linda K Johnson, Terry L Ng, John C Cambier, Eric T Clambey, James C Costello, Alan J Korman, Dan Theodorescu
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Science advances 5 (2) (2019)